US 2024/0392019 A1Published application

Anti-il-36r antibodies for the treatment of neutrophilic dermatoses

AssigneeBoehringer Ingelheim International GmbH

InventorsJay FINE, Janine LAMAR, Steven John PADULA, Meera RAMANUJAM, Sudha VISVANATHAN

Life of this patent

Estimating the term…

Abstract

The present invention provides methods for treating, preventing or ameliorating a neutrophilic dermatosis. The methods of the present invention include administering to a patient suffering from a neutrophilic dermatosis a pharmaceutical composition including an anti-interleukin-36 receptor (anti-IL-36R) antibody.

Claims8

Dependent claims

A method for treating Netherton syndrome (NS) in a subject comprising administering to the subject a therapeutically effective amount of an anti-interleukin-36 receptor (anti-IL-36R) antibody.

Dependencies are inferred from the claim text.

Facts

Application: 18/798,981Filed 9 Aug 2024
Priority: 17 Jul 2020
Published: 28 Nov 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 16/2866
Against receptors, cell surface antigens or cell surface determinants: against receptors for cytokines, lymphokines, interferons
A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines
A61P 17/00
Drugs for dermatological disorders
A61K 2039/505
Medicinal preparations containing antigens or antibodies: comprising antibodies

Family

Application63/053,129Us provisional application · filed 17 Jul 2020
Application17/376,233Continuation · filed 15 Jul 2021
Application18/798,981Continuation
US 12,098,207 B2Related patent
US 2022/0073628 A1Published application
US 2024/0392019 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results